Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endo International PLC (NASDAQ:ENDP)

17.34
Delayed Data
As of Jul 26
 -0.37 / -2.09%
Today’s Change
12.56
Today|||52-Week Range
88.54
-71.68%
Year-to-Date
3 Cheap Healthcare Stocks You Can Buy Right Now
Jul 21 / MotleyFool.com - Paid Partner Content
Weitz Funds' 2nd Quarter 2016 Value Fund Commentary
Jul 20 / GuruFocus News - Paid Partner Content
Weitz Funds Comments on Endo International
Jul 20 / GuruFocus News - Paid Partner Content
Wally Weitz's Partners Value Fund 2Q 2016 Quarterly Commentary
Jul 20 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close17.71
Today’s open17.59
Day’s range17.15 - 17.88
Volume3,902,341
Average volume (3 months)9,352,997
Market cap$3.9B
Dividend yield--
Data as of 07/26/2016

Growth & Valuation

Earnings growth (last year)-55.88%
Earnings growth (this year)-2.17%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+13.61%
P/E ratioNM
Price/Sales3.69
Price/Book0.65

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc-0.32-0.96%
ICPTIntercept Pharmaceut...+1.09+0.69%
ACADACADIA Pharmaceutica...+0.48+1.32%
PTHNPatheon NV+0.04+0.16%
Data as of 07/26/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.78
Annual revenue (last year)$3.3B
Annual profit (last year)-$1.5B
Net profit margin-9.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Rajiv De Silva
SVP-Operations, Research &
Development Strategy
Robert J. Cobuzzi
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs